日报更新时间：
周报更新时间：04-18 04:06
今开价：31.7
最高价：32.24
成交量：1338526.0
昨收价：31.6
最低价：31.545
最新价：32.2
英文名称：Avantor, Inc.
行业：工业
简介：Avantor, Inc.于2017年5月在特拉华州注册成立。该公司是为生物制药，医疗保健，教育和政府以及先进技术和应用材料行业的客户提供关键任务产品和服务的全球领先供应商。他们的综合产品……
电话：1-610-3861700
1904年，Avantor, Inc.以J.T. Baker Chemical Company之名成立，2010年，公司被New Mountain Capital, LLC的附属公司收购，后，公司于2016年和2017年先后收购了NuSil（创立于1985）和VWR（创立于1852年），在收购VWR后，2017年5月，公司以Avantor, Inc.之名重新注册成立。艾万拓公司的综合产品包括材料和消耗品，设备和仪器以及服务和专业采购，公司的客户同场依赖这些产品，因为这些产品经常被指定用于他们的研究、开发和生产过程。艾万拓公司与客户密切合作，使他们能够开发新的创新产品，降低开发和生产成本，改善产品或工艺性能特征，并提高他们生产的药品，设备和其他产品的安全性和可靠性。除了依赖公司的产品外，许多客户还依赖艾万拓公司的服务。Avantor的本地业务与他们的全球基础设施相结合，并促进与客户的成功合作关系，并将公司连接到180多个国家的240,000多个地点。Avantor的使命是推动科学发展，创造一个更美好的世界。艾万拓公司产品组合的深度和广度为公司的客户提供全面的产品和服务，使其能够为客户创建定制的集成解决方案。Avantor在发现，研究，开发和生产过程中向客户销售的精选产品包括： 材料和耗材：超高纯度化学品和试剂，实验室产品和用品，高度专业化的配方硅胶材料，定制辅料，定制一次性组件，工艺色谱树脂和色谱柱，分析样品制备试剂盒以及教育和微生物学和临床试剂盒。2018年，Avantor收入的33％来自专有材料和消耗品的销售，公司收入的40％来自第三方材料和消耗品。 设备和仪器仪表：过滤系统，病毒灭活系统，培养箱，分析仪器，蒸发器，超低温冰柜，生物安全柜和关键环境用品。 服务和专业采购：实验室和生产、临床、设备、采购和生物制药材料的扩大和开发服务。艾万拓公司在为各种工作流程开发，定制，制造和供应产品方面拥有深厚的专业知识，使公司能够在客户产品的整个生命周期内提供量身定制的解决方案。总的来说，Avantor提供约600万种产品，包括公司生产的产品以及全球约4,000家核心供应商的产品。Avantor生产的产品满足或超过了许多高度监管行业客户的苛刻要求。Avantor的高纯度和超高纯度产品，例如其J.T.Baker和SeaStar品牌化学品，受到全球生命科学和电子材料客户的信赖，并且可以按照每万亿分之一的严格纯度进行生产。同样，Avantor的NuSil品牌的高纯度定制有机硅已被领先的医疗设备制造商和航空航天公司信赖了三十多年。在客户工作流程的每一步，艾万拓都会分享公司的科学和工作流程专业知识，以帮助为现有客户产品和流程提供渐进和可持续的改进。 这些项目包括提高产品纯度，从而提高其性能特征，改进产品包装和简化工作流程。 艾万拓的战略计划包括在新兴科学领域开发新产品，如细胞和基因治疗。 还是目前与客户共有约1,400个创新项目，旨在解决现有产品的流程改进以及公司支持的潜在重大新机遇。
| 机构持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Franklin Advisers, Inc. | 840500 | 0.16% | 192500 | 29.71% | 2019-07-31 |
| PGIM Investments LLC | 2888998 | 0.54% | -543917 | -15.84% | 2019-07-31 |
| John Hancock Investment Management LLC | 2936430 | 0.55% | 2936430 | -- | 2019-07-31 |
| BlackRock Advisors LLC | 5163365 | 0.97% | -112350 | -2.13% | 2019-07-31 |
| Vanguard Investments Australia Ltd | 6053151 | 1.13% | 2466306 | 68.76% | 2019-07-31 |
| Fidelity SelectCo, LLC | 7464000 | 1.40% | 200000 | 2.75% | 2019-07-31 |
| Fidelity Management & Research Company | 14774715 | 2.77% | 229847 | 1.58% | 2019-07-31 |
| Teachers Advisors LLC | 18812066 | 3.52% | 18812066 | -- | 2019-07-31 |
| Vanguard Group Inc | 19565931 | 3.66% | 7423321 | 61.13% | 2019-07-31 |
| MML Investment Advisers, LLC | 2426890 | 0.45% | 2426890 | -- | 2019-07-31 |
| Invesco Advisers, Inc. | 2382384 | 0.45% | 2382384 | -- | 2019-07-31 |
| Charles Schwab Investment Management Inc | 900067 | 0.17% | 9231 | 1.04% | 2019-07-31 |
| Advanced Series Trust | 992580 | 0.19% | -- | -- | 2019-07-31 |
| Voya Investments, LLC | 1192661 | 0.22% | 1192661 | -- | 2019-07-31 |
| Carillon Tower Advisers, Inc. | 1579659 | 0.30% | 1579659 | -- | 2019-07-31 |
| Principal Global Investors, LLC | 1639216 | 0.31% | 74996 | 4.79% | 2019-07-31 |
| Robeco Institutional Asset Mgmt BV | 1682161 | 0.31% | -28643 | -1.67% | 2019-07-31 |
| T. Rowe Price | 2143160 | 0.40% | 2143160 | -- | 2019-07-31 |
| Polar Capital LLP | 2264049 | 0.42% | 429521 | 23.41% | 2019-07-31 |
| T. Rowe Price Associates, Inc. | 30960782 | 5.79% | 30960782 | -- | 2019-07-31 |
| Penn Mutual Asset Management LLC | 603318 | 0.11% | 603318 | -- | 2019-06-30 |
| T. Rowe Price International Limited | 789925 | 0.15% | 929 | 0.12% | 2019-06-30 |
| Transamerica Asset Management, Inc | 1630090 | 0.31% | 1623554 | 24840.18% | 2019-06-30 |
| Northern Trust Investments Inc | 553891 | 0.10% | 553891 | -- | 2019-06-30 |
| Hartford Funds Management Company, LLC | 494002 | 0.09% | 494002 | -- | 2019-06-30 |
| Strategic Advisers LLC | 490000 | 0.09% | 490000 | -- | 2019-06-30 |
| Olive Street Investment Advisers, LLC | 277111 | 0.05% | 277111 | -- | 2019-06-30 |
| First Trust Advisors L.P. | 304486 | 0.06% | -- | -- | 2019-06-30 |
| Pacific Life Fund Advisors LLC (PLFA) | 333408 | 0.06% | 333408 | -- | 2019-06-30 |
| BlackRock | 453857 | 0.08% | 453857 | -- | 2019-06-30 |
| K2/D&S Management Co., L.L.C. | 191320 | 0.04% | 191320 | -- | 2019-06-30 |
| BlackRock Fund Advisors | 150494 | 0.03% | -- | -- | 2019-06-30 |
| State Street Global Advisors | 11700 | -- | 11700 | -- | 2019-06-30 |
| (Junk) Columbia Management Investment Advisers, LLC | 31064 | 0.01% | 31064 | -- | 2019-06-30 |
| Vanguard | 34762 | 0.01% | 34762 | -- | 2019-06-30 |
| Renaissance Capital LLC | 63794 | 0.01% | -- | -- | 2019-06-30 |
| Morningstar Investment Management LLC | 136260 | 0.03% | 136260 | -- | 2019-06-30 |
| Vanguard Investments Canada Inc | 499 | -- | 499 | -- | 2019-05-31 |
| Barclays Bank PLC | 4055 | -- | 4055 | -- | 2019-05-31 |
| BlackRock Asset Management Canada Ltd | 145628 | 0.03% | -1 | -- | 2019-05-31 |
| 共同基金持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Invesco American Franchise Fund | 1875669 | 0.33% | 1875669 | -- | 2019-06-30 |
| T. Rowe Price Mid-Cap Growth Fund | 11500000 | 2.02% | 11500000 | -- | 2019-06-30 |
| CREF Growth Account | 9001358 | 1.58% | 9001358 | -- | 2019-05-31 |
| CREF Stock Account | 6691222 | 1.18% | 6691222 | -- | 2019-05-31 |
| T. Rowe Price Institutional Lrg Cp Gr Fd | 6640773 | 1.17% | 6640773 | -- | 2019-06-30 |
| Vanguard Total Stock Market Index Fund | 6053151 | 1.06% | 2466306 | 68.76% | 2019-06-30 |
| Vanguard Small Cap Index | 5784637 | 1.02% | 2471293 | 74.59% | 2019-06-30 |
| T. Rowe Price Capital Appreciation Fund | 4870986 | 0.86% | 4870986 | -- | 2019-06-30 |
| T. Rowe Price Health Sciences Fund | 4398772 | 0.77% | 4398772 | -- | 2019-06-30 |
| Vanguard Small Cap Growth Index Fund | 3314203 | 0.58% | 2376466 | 253.43% | 2019-06-30 |
| Vanguard Extended Market Index Fund | 3021543 | 0.53% | 576941 | 23.60% | 2019-06-30 |
| Fidelity | 2059800 | 0.36% | 357700 | 21.02% | 2019-06-30 |
| PGIM Jennison Health Sciences Fund | 2145569 | 0.38% | -- | -- | 2019-06-30 |
| MassMutual Select Mid Cap Growth Fund | 2192000 | 0.39% | 2192000 | -- | 2019-06-30 |
| BlackRock Health Sciences Opps Port | 2343080 | 0.41% | -- | -- | 2019-06-30 |
| JHancock Disciplined Value Mid Cap Fund | 2549327 | 0.45% | 2549327 | -- | 2019-05-31 |
| BlackRock Mid-Cap Growth Equity Port | 2673741 | 0.47% | -- | -- | 2019-06-30 |
| T. Rowe Price Instl Mid-Cap Eq Gr Fd | 2844000 | 0.50% | 2844000 | -- | 2019-06-30 |
| Polar Capital Healthcare Opps Fund | 1727234 | 0.32% | 1727234 | -- | 2019-05-31 |
| Fidelity Advisor | 1774900 | 0.33% | 1774900 | -- | 2019-05-31 |
| TIAA-CREF Growth & Income Fund | 1372212 | 0.26% | 1372212 | -- | 2019-05-31 |
| Robeco BP US Premium Equities | 1495541 | 0.28% | 1495541 | -- | 2019-05-31 |
| Carillon Eagle Mid Cap Growth Fund | 1579659 | 0.30% | 1579659 | -- | 2019-06-30 |
| Transamerica Large Cap Value Fund | 1625000 | 0.30% | 1625000 | -- | 2019-05-31 |
| AST T. Rowe Price Large-Cap Growth Port | 992580 | 0.19% | 992580 | -- | 2019-05-31 |
| Vanguard Small Cap Value Index Fund | 1050729 | 0.20% | 1050729 | -- | 2019-05-31 |
| PGIM Jennison Small Company Fund | 1287346 | 0.24% | 1287346 | -- | 2019-05-31 |
| Principal LargeCap Growth Fund I | 1370777 | 0.26% | 1370777 | -- | 2019-05-31 |
| Franklin Small-Mid Cap Growth Fund | 575500 | 0.11% | 575500 | -- | 2019-05-31 |
| Vanguard Health Care Index Fund | 463010 | 0.09% | 463010 | -- | 2019-05-31 |
| Schwab US Mid-Cap ETF | 431067 | 0.08% | 197 | 0.05% | 2019-06-28 |
| Hartford Healthcare Fund | 420700 | 0.08% | 420700 | -- | 2019-05-31 |
| First Trust US Equity Opportunities ETF | 302323 | 0.06% | 1956 | 0.65% | 2019-06-27 |
| BlackRock Event Driven Equity Fund | 258894 | 0.05% | 258894 | -- | 2019-05-31 |
| Robeco BP US Select Opportunities Eqs | 215263 | 0.04% | 215263 | -- | 2019-05-31 |
| Pacific Select Fund Mid-Cap Value Port | 203384 | 0.04% | 203384 | -- | 2019-05-31 |
| Vanguard Instl Total Stock Market Idx Fd | 173952 | 0.03% | 173952 | -- | 2019-05-31 |
| iShares Core Balanced ETF Portfolio | 145454 | 0.03% | -- | -- | 2019-05-30 |
| Schwab US Large-Cap ETF | 133505 | 0.02% | 270 | 0.20% | 2019-05-31 |
| Principal MidCap Growth Fund III | 139333 | 0.03% | 139333 | -- | 2019-05-31 |
| iShares Core S&P Total US Stock Mkt ETF | 145454 | 0.03% | -- | -- | 2019-05-31 |
| iShares Core S&P US Total Market ETF | 145454 | 0.03% | -- | -- | 2019-05-30 |
| Schwab US Large-Cap Growth ETF | 111158 | 0.02% | -- | -- | 2019-05-31 |
| Schwab US Broad Market ETF | 105574 | 0.02% | -25 | -0.02% | 2019-05-31 |
| State Street US Total Market Index Fund | 11700 | -- | 11700 | -- | 2019-05-31 |
| Aegon Large Cap Value Fund | 6536 | -- | 6536 | -- | 2019-05-31 |
| GlobalAccess US Small & Mid Cap Eq Fd | 4055 | -- | 4055 | -- | 2019-05-31 |
| iShares Core S&P US Total Mkt ETF CADH | 174 | -- | -1 | -0.57% | 2019-05-30 |
| Pacific Select Fund Health Sciences | 130024 | 0.02% | 130024 | -- | 2019-05-31 |
| Rajiv Lochan Gupta | Rajiv Lochan Gupta is a businessperson who has been the head of 10 different companies and currently occupies the position of Independent Non-Executive Chairman for Aptiv Plc, Chairman of Delphi Automotive LLP (a subsidiary of Aptiv Plc) and Chairman at Avantor, Inc., Chairman at Avantor Performance Materials, Inc. (a subsidiary of Avantor, Inc.). Mr. Gupta is also on the board of Arconic Defense, Inc., DuPont de Nemours, Inc. and Arconic, Inc. In his past career Mr. Gupta was Lead Independent Director at HP, Inc., Chairman at American Chemistry Council, Inc., Director at Information Resources, Inc., Chairman & Chief Executive Officer of Rohm & Haas Co., Chairman for J.T. Baker Holdings, Inc. and Chairman-American Section at Society of Chemical Industry. Rajiv Lochan Gupta received a graduate degree from Cornell University, an MBA from Drexel University and an undergraduate degree from Indian Institute of Technology Bombay. |
|---|---|
| Rakesh Sachdev | Rakesh Sachdev is a businessperson who has been at the head of 5 different companies. Currently, Mr. Sachdev is Chairman of Regal Beloit Corp. and Chairman of Aceto Corp. Mr. Sachdev is also on the board of 7 other companies. In the past he was Chief Administrative Officer & MD-Emerging Markets at Arvin Innovation, Inc., Executive Director & CFO-Automotive Business Unit at Cummins, Inc. and Chief Financial Officer-Automotive Business Unit at Cummins Engine Co., Inc. (a subsidiary of Cummins, Inc.), President-Asia Pacific at Meritor, Inc. and Senior Vice President & President-Asia Pacific at ArvinMeritor, Inc. (a subsidiary of Meritor, Inc.), President, Chief Executive Officer & Director at Sigma-Aldrich Corp. and President, Chief Executive Officer & Director at Sigma-Aldrich Co. LLC (Missouri). Mr. Sachdev received an undergraduate degree from Indian Institute of Technology New Delhi, a graduate degree from the University of Illinois and an MBA from Kelley School of Business. |
| Thomas A. Szlosek | Presently, Thomas A. Szlosek is Chief Financial Officer & Executive VP for Avantor, Inc. In his past career he occupied the position of Chief Financial Officer & Senior Vice President for Honeywell International, Inc. and CFO-Asian Medical Systems at General Electric Co. He received an undergraduate degree from State University of New York College at Geneseo. |
| Charles R. Kummeth | Presently, Charles R. Kummeth is President, Chief Executive Officer & Director at Bio-Techne Corp. and Chief Executive Officer for Research & Diagnostic Systems, Inc., Chief Executive Officer at ProteinSimple, Inc. and President & Director at CyVek, Inc. (which are all subsidiaries of Bio-Techne Corp.). Charles R. Kummeth is also on the board of 6 other companies. In the past Mr. Kummeth was President-Mass Spectrometry & Chromatography at Thermo Fisher Scientific, Inc. and Vice President-Medical Division at 3M Co. Mr. Kummeth received an undergraduate degree from the University of North Dakota, a graduate degree from the University of St. Thomas (Minnesota) and an MBA from The Curtis L. Carlson School of Management. |
| Matthew S. Holt | Currently, Matthew S. Holt occupies the position of Chairman at Signify Health LLC, Chairman at Convey Health Solutions, Inc., Chairman for CIOX Health LLC, Chairman for Cytel, Inc. and Managing Director at New Mountain Capital LLC. Mr. Holt is also on the board of 6 other companies. He previously occupied the position of Principal at Lehman Brothers Holdings, Inc. He received an undergraduate degree from Harvard College. |
| Andre V. Moura | Presently, Andre V. Moura is Chairman for Topix Pharmaceuticals, Inc. and Chairman of Stearn's Products, Inc. (a subsidiary of Topix Pharmaceuticals, Inc.) and Managing Director at New Mountain Capital LLC. Mr. Moura is also on the board of 5 other companies. Mr. Moura previously occupied the position of Principal at McKinsey & Co., Inc. He received an MBA from Harvard Business School and an undergraduate degree from Harvard College. |
| Frederic Vanderhaegen | Frederic Vanderhaegen is Executive Vice President-Europe Region at Avantor, Inc. In the past he occupied the position of Executive VP & Head-Life Sciences Business at Tecan Group AG, Vice President & General Manager-EMEA Division at Ortho-Clinical Diagnostics and Vice President-Sales for Beckman Coulter, Inc. He received an undergraduate degree from Universit�0�1�0�8 Libre de Bruxelles, an undergraduate degree from Haute �0�1‰cole Lucia de Brouck�0�1¨re and an MBA from Open University Malaysia. |
| Thomas Connolly | Thomas Connolly is on the board of Union College (New York) and Avantor, Inc. He received an undergraduate degree from Union College (New York). |
| Eric A. McAllister | Eric A. McAllister is Chief Human Resources Officer & Executive VP at Avantor, Inc. Mr. McAllister previously held the position of Senior Vice President-Human Resources for Westinghouse Electric Co. LLC, Senior Director-Human Resources at Microsoft Corp., Global Vice President-Human Resources at Danaher Corp., Principal at Watson Wyatt & Co. Holdings, Principal at Motorola, Inc., Principal at Accenture LLC and Chief Human Resources Officer & Vice President at Omniture, Inc. Mr. McAllister received an undergraduate degree from Brigham Young University and an MBA from Kellogg School of Management. |
| Corey Walker | Corey Walker is EVP-Americas, Biomaterials & Advanced Technologies at Avantor, Inc. In his past career Mr. Walker occupied the position of Safety Manager at Southam & Associates, Inc., Global Vice President at Sperry Drilling Services and Global VP-Multichem Global Business Groups at Halliburton Energy Services, Inc. He received an undergraduate degree from Brigham Young University and an MBA from Harvard Business School. |
| Jonathan M. Peacock | Founder of Arix Bioscience Plc, Jonathan M. Peacock currently holds the position of Non-Executive Chairman of Arix Bioscience Plc and Chairman of Bellerophon Therapeutics, Inc. He is also on the board of Onyx Pharmaceuticals, Inc., Los Angeles County Museum of Natural History, Avantor, Inc. and Socati Corp. In his past career Mr. Peacock occupied the position of Chief Financial Officer & Executive Vice President of Amgen, Inc. Chief Financial Officer, Director & Executive VP at Amgen Rockville, Inc. and Chief Financial Officer for Amgen Ventures LLC (both are subsidiaries of Amgen, Inc.), Partner at McKinsey & Co., Inc., Chief Financial & Administrative Officer at Novartis AG and Partner at PricewaterhouseCoopers LLP. He received a graduate degree from the University of St. Andrews. |
| Ashish K. Kulkarni | Presently, Ashish K. Kulkarni is Chief Technology Officer & Executive VP at Avantor, Inc. He is also on the board of Biohealth Innovation, Inc. In his past career he was Chief Technology & Innovation Officer at Celanese Corp., Vice President-Global Engineering at United Technologies Corp., Process & Product Engineer at General Electric Co. and Vice President-Global Engineering at American Standard Cos., Inc. He received a doctorate from Rensselaer Polytechnic Institute and an undergraduate degree from Osmania University. |
| Michael Stubblefield | Currently, Michael Stubblefield is President, Chief Executive Officer & Director at Avantor, Inc. and Chief Executive Officer for Avantor Performance Materials, Inc. (a subsidiary of Avantor, Inc.). In the past he held the position of VP & General Manager-Advanced Engineered Materials at Celanese Corp. Michael Stubblefield received an undergraduate degree from the University of Utah and an MBA from Texas A&M University-Corpus Christi. |
| Christi L. Shaw | Ms. Christi L. Shaw is a Chief Executive Officer-Kite at Gilead Sciences, Inc. and a President-Bio Medicines & Senior Vice President at Eli Lilly & Co. She is on the Board of Directors at Avantor, Inc. Ms. Shaw was previously employed as a President by Novartis Pharmaceuticals Corp., a VP-New Business Development & Strategic Analytics by Ethicon Corp., a Group Product Director by Ortho-McNeil-Janssen Pharmaceuticals, Inc., and a Principal by Johnson & Johnson. She also served on the board at Biotechnology Innovation Organization, Healthcare Leadership Council and The Young Women's Leadership Network, Inc. She received her undergraduate degree from Iowa State University and an MBA from the University of Wisconsin. |
| Christophe Couturier | Christophe Couturier is EVP-Services, Strategy & Business Transformation at Avantor, Inc. In his past career Mr. Couturier occupied the position of Chief Executive Officer of Salicornia LLC, Head-Finance for Novartis AG, Senior Vice President & General Manager at Merck KGaA, Finance Director for Lloyds Pharmacy Ltd., Chief Financial Officer of OvaScience, Inc. and Associate Partner at IBM Business Consulting Services, Inc. Christophe Couturier received an MBA from ESSEC Business School. |
| Devashish Ohri | Devashish Ohri is on the board of Avantor Performance Materials India Ltd. and Executive Vice President-AMEA Region at Avantor, Inc. In the past he occupied the position of Managing Director-South Asia Region at Life Technologies, Inc. He received a graduate degree from the University of Delhi and an MBA from INSEAD. |
| Steven W. Eck | Currently, Steven W. Eck is Chief Accounting Officer & Senior Vice President at Avantor, Inc. In his past career Mr. Eck was Chief Accounting Officer for CSS Industries, Inc. He received an undergraduate degree from Muhlenberg College. |
| Bjorn Hofman | Presently, Bjorn Hofman is Chief Operating Officer & Executive Vice President for Avantor, Inc. Mr. Hofman previously occupied the position of Business Director-EMEA Region at Celanese Corp. and Senior Vice President-Advanced Technologies at Merck KGaA. Mr. Hofman received a graduate degree from Delft University of Technology. |
| Justin Miller | Presently, Justin Miller occupies the position of Secretary, Executive VP & General Counsel of Avantor, Inc. In the past Mr. Miller held the position of Attorney at Ballard Spahr LLP and Associate General Counsel at E.I. du Pont de Nemours & Co. He received an undergraduate degree from the University of Pennsylvania and a graduate degree from George Mason University School of Law. |
| Michael Wondrasch | Michael Wondrasch is Chief Information Officer & Executive VP for Avantor, Inc. In his past career he held the position of Vice President-Technology at AmerisourceBergen Corp., Global Chief Technology Officer at Bunge Ltd. and Chief Technology Officer & Senior Vice President for PepsiCo, Inc. He received an undergraduate degree from Villanova University and a graduate degree from the University of Pennsylvania. |
| Thomas Connolly | Thomas Connolly is on the board of Union College (New York) and Avantor, Inc. He received an undergraduate degree from Union College (New York). |
| Jo Natauri | Jo Natauri is on the board of Safe Horizon, Inc. and Avantor, Inc. Jo Natauri received an undergraduate degree from the University of Virginia. |
| James Bramwell | James Bramwell is Executive Vice President-Strategic Partners at Avantor, Inc. In the past Mr. Bramwell was Senior VP-Strategic Partners & Global Export at VWR Corp. and President at VWR Foundation. Mr. Bramwell received an undergraduate degree from Brigham Young University. |
| Gerard Brophy | Gerard Brophy is Executive Vice President-Biopharma Production at Avantor, Inc. Mr. Brophy received an undergraduate degree and a doctorate from Dublin City University. |
| Michael J. Depetris | Currently, Michael J. Depetris occupies the position of Chief Audit Executive & Senior Vice President at Avantor, Inc. |
abu_quant
扫一扫关注阿布量化
热门推荐
全部评论 0
暂无评论